(Q34387349)

1 August 2017

title

Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression (English)

1 reference

1 August 2017

0 references

Françoise Brun-Vézinet

11

object named as

Françoise Brun-Vézinet

1 reference

1 August 2017

7

Geneviève Chêne

1 reference

1 August 2017

Sophie Matheron

9

0 references

Diane Descamps

10

object named as

Diane Descamps

1 reference

1 August 2017

1

Rodolphe Thiébaut

1 reference

1 August 2017

Charlotte Charpentier

2

object named as

Charlotte Charpentier

1 reference

1 August 2017

3

Florence Damond

1 reference

1 August 2017

4

Audrey Taieb

1 reference

1 August 2017

Romain Antoine

5

1 reference

1 August 2017

Jacqueline Capeau

6

1 reference

1 August 2017

Gilles Collin

8

1 reference

1 August 2017

French ANRS HIV-2 CO5 Cohort

12

1 reference

1 August 2017

language of work or name

English

0 references

publication date

20 August 2012

1 reference

Clinical Infectious Diseases

1 August 2017

published in

1 reference

1 August 2017

volume

55

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1417-1425

1 reference

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Update on human immunodeficiency virus (HIV)-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

HIV infection, inflammation, immunosenescence, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Plasma levels of soluble CD14 independently predict mortality in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Association of low level viremia with inflammation and mortality in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Direct relationship between virus load and systemic immune activation in HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Bivariate linear mixed models using SAS proc MIXED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

Microbial Translocation Correlates with the Severity of Both HIV‐1 and HIV‐2 Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS708

21 January 2018

Identifiers

DOI

10.1093/CID/CIS708

1 reference

1 August 2017

1 reference